Skip to main content

Research Repository

Advanced Search

Provision and standards of care for treatment and follow-up of patients with Autoimmune Hepatitis (AIH)

Gordon, Victoria Mary; Adhikary, Ratul; Aithal, Guruprasad P; Appleby, Victoria; Das, Debasish; Day, James; Delahooke, Toby; Dixon, Selena; Elphick, David; Hardie, Claire; Heneghan, Michael; Hoeroldt, Barbara; Hooper, Patricia; Hutchinson, John; Jones, Rebecca L; Khan, Faisal; Metcalf, Jane; Nkhoma, Alick; Pelitari, Stavroula; Prince, Martin; Prosser, Annell; Saksena, Sushma; Sathyanarayana, Vinay; Vani, Deven; Yeoman, Andrew; Gleeson, Dermot

Provision and standards of care for treatment and follow-up of patients with Autoimmune Hepatitis (AIH) Thumbnail


Authors

Victoria Mary Gordon

Ratul Adhikary

Victoria Appleby

Debasish Das

James Day

Toby Delahooke

Selena Dixon

David Elphick

Claire Hardie

Michael Heneghan

Barbara Hoeroldt

Patricia Hooper

John Hutchinson

Rebecca L Jones

Faisal Khan

Jane Metcalf

Alick Nkhoma

Stavroula Pelitari

Martin Prince

Annell Prosser

Sushma Saksena

Vinay Sathyanarayana

Deven Vani

Andrew Yeoman

Dermot Gleeson



Abstract

Background Autoimmune hepatitis (AIH) is a substantial UK health burden, but there is variation in care, facilities and in opinion regarding management. We conducted an audit of service provision and care of patients with AIH in 28 UK hospitals. Methods Centres provided information about staffing, infrastructure and patient management (measured against predefined guideline-based standards) via a web-based data collection tool. Results Hospitals (14 university hospitals (UHs), 14 district general hospitals (DGHs)) had median (range) of 8 (3-23) gastroenterologists; including 3 (0-10) hepatologists. Eight hospitals (29%, all DGHs) had no hepatologist. In individual hospital departments, there were 50% (18-100) of all consultants managing AIH: in DGH's 92% (20-100) vs 46% (17-100) in UHs. Specialist nurses managed AIH in only 18%. Seventeen (61%) hospitals had a histopathologist with a liver interest, these were more likely to find rosettes than those without (172/795 vs 50/368; p<0.001). Of 999 steroid-treated patients with ≥12 months follow-up, 25% received steroids for <12 months. After 1 year of treatment, 82% of patients achieved normal serum alanine aminotransaminase (ALT); this was higher in UHs than DGHs. Three-monthly liver blood tests were inadequately recorded in 26%. Of potentially eligible patients with liver decompensation, transplantation was apparently not considered in 5% (n=7). The same standards were attained in different types of hospital. Conclusion Management of AIH in UK hospitals is often shared between most gastroenterologists. Blood test monitoring and treatment duration are not always in line with recommendations. Some eligible patients with decompensation are not discussed with transplant teams. Care might be improved by expanding specialist input and management by fewer designated consultants.

Citation

Gordon, V. M., Adhikary, R., Aithal, G. P., Appleby, V., Das, D., Day, J., …Gleeson, D. (2022). Provision and standards of care for treatment and follow-up of patients with Autoimmune Hepatitis (AIH). Frontline Gastroenterology, 13(2), 126-132. https://doi.org/10.1136/flgastro-2020-101661

Journal Article Type Article
Acceptance Date Mar 18, 2021
Online Publication Date May 18, 2021
Publication Date 2022-03
Deposit Date Apr 4, 2024
Publicly Available Date Apr 19, 2024
Journal Frontline Gastroenterology
Print ISSN 2041-4137
Electronic ISSN 2041-4145
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 13
Issue 2
Pages 126-132
DOI https://doi.org/10.1136/flgastro-2020-101661
Public URL https://nottingham-repository.worktribe.com/output/32755605
Publisher URL https://fg.bmj.com/content/13/2/126